Cambridge, October 13 — A new study from Cambridge University has found that women with autoimmune conditions are more likely to be told their symptoms are psychological and face longer delays in receiving treatment compared to men. The research, published in the journal Rheumatology, reviewed medical records of over 11,000 patients and revealed that women were 30% more likely to be diagnosed with autoimmune conditions than men. On average, women waited 1.5 years longer than men to receive treatment after symptoms first appeared.
These findings suggest a persistent gap in how autoimmune diseases are recognised and managed across genders, pointing to potential biases in early diagnosis. The encouraging part is that increased awareness among clinicians could help close this gap and lead to earlier, more accurate diagnoses for all patients.
Patients should feel empowered to discuss their symptoms openly and seek second opinions if they feel their concerns are not being taken seriously. Talk to your doctor about any persistent symptoms, especially if they involve fatigue, joint pain, or unexplained inflammation. Consult your doctor for medical advice. Autoimmune diseases, in which the immune system mistakenly attacks the body’s own tissues, have long been recognized as disproportionately affecting women, though the reasons remain an active area of research.
Conditions such as lupus, rheumatoid arthritis, and multiple sclerosis occur more frequently in female patients, and clinical guidelines have increasingly emphasized the importance of early intervention to prevent irreversible organ damage and disability. Medical literature has documented a historical pattern in which women’s reports of pain and nonspecific symptoms are more often attributed to psychological or psychosomatic causes, a tendency that can delay referral to specialists and appropriate testing.
Studies across multiple health systems have shown that diagnostic pathways for complex, multisystem illnesses tend to be longer for female patients, particularly when symptoms overlap with common conditions such as fibromyalgia or chronic fatigue syndrome. Efforts to reduce these disparities have included updates to medical curricula, the development of gender-specific diagnostic algorithms, and initiatives encouraging patients to track symptom patterns and request specific antibody panels when warranted. Researchers note that closing the diagnostic gap could improve long-term outcomes and reduce healthcare costs associated with advanced disease management.
